Radical Prostatectomy: A Critical Analysis of Surgical Quality Between the Open and Laparoscopic Approaches. Karim Touijer, MD.

Slides:



Advertisements
Similar presentations
HELIOS Kliniken Leipziger Land Folie: 1 K. Kuhnt D. Schulz NESA DAYS 2006 Positive margins and early postop potency after Nerve-sparing ELRP Kai Kuhnt.
Advertisements

CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS
50 Vs 50 A Comparison of the Oncologic Outcomes of Retropubic Prostatectomy and Robotic Prostatectomy Chris Ogden Tim Christmas Jordan Durrant Khalid A.
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
CARBON ION THERAPY FOR SACRAL CHORDOMAS
No. 091 Bipolar Diathermy for Transurethral Resection of Prostate: 6 year Australian Single Regional Centre Experience Devang Desai (Urology Registrar),
The Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer ChartbookAugust 2014.
الجامعة السورية الخاصة كلية الطب البشري قسم الجراحة Perioperative management of the high-risk surgical patient Dr. M.A.Kubtan, MD - FRCS.
CMS Core Measures Evidence-Based Performance Measurement.
EXTRAPERITONEAL RADICAL PROSTATECTOMY AND PREVIOUS HISTORY OF HERNIA REPAIR: EVALUATION OF RESULTS SELCUK KESKIN, GUILLAUME GUICHARD, ÁNDRAS HOZNEK, ALEXANDRE.
WHICH NEPHRECTOMY. laparoscopic nephrectomy Simple laparoscopic nephrectomy. Donor laparoscopic nephrectomy. Radical laparoscopic nephrectomy. Partial.
Management of T1 Kidney Cancer Laparoscopic Surgery
Role of MRI and MRSI in The Management of Prostate Cancer Karim Touijer, MD.
Mr Jonathan Lewin MBBS, MRCS, MD, FRCS(Urol), FRACS Consultant Uro-Oncological Surgeon.
Radical Prostatectomy Sept 2009 till Aug 2010 South Mersey Cancer Network Manal Kumar Consultant Urologist.
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
Steven Joniau Filip Ameye
Modern Management of Prostate Cancer With Active Surveillance PROSTATE CANCER SYMPOSIUM NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE SEPTEMBER 10,
A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.
RISK OF NON SIGNIFICANT PROSTATE CANCER IN PROSTATE CANCER PATIENTS DIAGNOSED BY AN EXTENDED PROSTATE NEEDLE BIOPSY PROCEDURE AND TREATED BY RADICAL PROSTATECTOMY.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Creating Value with a da Vinci Surgery Program
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Prostate Cancer Treatment: What’s Best For You?
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Advances in Robotic Surgery:
Laparoscopic Radical Prostatectomy: Oncological and Functional Outcomes Following Fellowship Training. Introduction Radical Prostatectomy (RP) is a technically.
Rashid TG, Dudderidge T, Zahur S, Kini M, Ogden CW.
Clinical Efficacy and Anatomical Basis for A Cavernosal Nerve Interposition Graft Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical.
Journal Club : Relationship between Intraoperative Mean Arterial Pressure and Clinical Outcomes after Noncardiac Surgery Toward an Empirical Definition.
Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from.
The significance of extracapsular lymph node involvement in node- positive patients with adenocarcinoma of the distal oesophagus or gastro-oesophageal.
Introducing a new and simple scoring system to evaluate oncological and functional outcome after radical prostatectomy Salomon L., De La Taille A., Vordos.
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
* AP: Anteroposterior, Lat: Lateral Tumor diameter, tumor length, depth of penetration, distance from the anal verge, deep and narrow pelvic dimension.
Healthcare Workforce and Regionalization of Services: Lung Cancer Resections Stephen C. Yang, M.D. Chief of Thoracic Surgery The Arthur B. and Patricia.
A comparison of open vs laparoscopic emergency colonic surgery; short term results from a district general hospital. D Vijayanand, A Haq, D Roberts, &
Oncology 11 Localised Prostate Cancer VIVA
The Guildford Experience Enhanced Recovery: The story so far…. Dr Wendy King Anaesthetic Department, Royal Surrey County Hospital, Guildford, UK January.
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Robot-assisted Laparoscopic Radical Cystectomy KH Rha Severance Hospital Yonsei University The 10 th Catholic International Urology Symposium, :30–14:50.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Surgical Management of Prostate Cancer
Robotic-assisted Laparoscopic Prostatectomy
International Neurourology Journal 2015;19:
Morcellation Techniques for Laparoscopic Hysterectomy and Myomectomy: A Retrospective Study Elsemieke Meurs, BSc Mobolaji Ajao, MD, Luiz Gustavo Brito,
Venous Thromboembolism Prophylaxis (VTE)
Surgical Treatment in Locally Advanced Prostate Cancer
Oesophagectomy Enhanced recovery Pathway
Bladder Cancer and Prostatic Cancer
New perioperative risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience in high volume Canadian.
Laparoscopic Radical prostatectomy: Is it still a treament of choice?
Advancing Gynaecological Surgery:
Post Op Positive Seminal Vesicle Case 4: Prostate_4
Volume 13, Issue 6, Pages (June 2012)
Prostate Cancer: Highlights from 2006
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
ROBOTIC ASSISSTED RADICAL PROSTATECTOMY OUR INITIAL EXPERIENCE
Apollo Gleneagles Hospitals,
Semiannual Report, March 2015
Short-term Outcomes of Transanal Total Mesorectal Excision
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Volume 13, Issue 6, Pages (June 2012)
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Nursing care of patients operated-on for CRC
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Presentation transcript:

Radical Prostatectomy: A Critical Analysis of Surgical Quality Between the Open and Laparoscopic Approaches. Karim Touijer, MD

Critical Quality Indicators Primary Quality Indicators Oncological Efficacy: Nodal Status Positive Surgical Margin Rate Biochemical Recurrence Rate Functional Outcome Potency recovery Urinary Continence Secondary Quality Indicators Equanimity OR Time Hospital stay Blood Loss Morbidity Transfusion Severity of complications Cost Cost

Patients Data January 2003 and June consecutive radical prostatectomies Transperitoneal laparoscopic Retropubic - 36 cases excluded for neo-adjuvant hormonal therapy 4 surgeons, 1 uropathologist

Clinical – Pathological Features

Preoperative Clinical Features LRPRRPP value Number of patients Age59.5 (+ 7)59 (+ 7)0.15 BMI27.8 (+ 3.6)28.1 (+ 4.2)0.4 PSA6.4 (+ 5)6.7 (+ 7)0.31 Clinical stage0.03 T1C72%65% T2A16% T2B7%8.5% T2C3%6% T3A2.5%4% Biopsy Gleason sum (median) Prostate volume (cc)36.2 (+ 17)37 (+ 24.7)0.64

LRPRRPP value Specimen weight (gm)43.9 (+ 15.1)43.3 (+ 22.1)0.73 Pathological Gleason sum %0.7% 638.4%40.7% 756.4%50.9% 83.1%3.5% 92.1%4.7% Pathological stage0.25 p00.6%1.2% pT273.2%67.5% pT325.1%29.7% pT41%1.4% Pathological Features

LRPRRPP value Seminal vesicles invasion3.5%5.1%0.2 Capsular status0.13 No invasion22.3%25.7% Invading into but not through 55.5%46.7% Focal (< 1mm)7.1%11.1% Established15.1%16.5%

Detailed Tumor Characteristics LRPRRPP value Total tumor volume (cc)1.7 (+ 2)1.9 (+ 2.9)0.18 Cancer maximum diameter (cm)1.7 (+ 0.8)1.7 (+ 0.9)0.87 Number of tumor foci3 (+ 1.8)2.9 (+ 1.6)0.35 Predominant site0.82 Peripheral zone56.8%58.4% Transitional zone17.1%15.9% Indolent cancer17.9%19%0.75 Organ confined non-indolent59%52.2%0.1

Oncological Efficacy 1.Nodal Status 2.Positive Surgical Margin rate 3.Biochemical Recurrence rate

Nodal Status LRPRRPP value Mean Median Overall % positivity6%5.9%0.96 % Positivity in high risk patients* 15.4%10.2%0.16 * In Patients with Partin’s Table LNI >1%

Positive Surgical Margin Rate Overall Positive Surgical Margin rate Positive Surgical margin rate by pathological stage Risk adjusted rate using the Partin Tables predicted probability of Organ confined for risk stratification

Positive Surgical Margins Analysis LRPRRPP value Overall PSM rate11.3%11%0.85 pT28.2%5.3%0.12 pT317.2%20.2%0.32

Risk Adjusted Analysis of PSM using Partin’s table predicted Probability of Organ Confined Disease p = 0.45 (Odds ratio: 1.156, 95% CI: 0.79 – 1.69)

Evolution Over Time of the PSM Rate For Each Surgical Approach LAP OPEN

Evolution Over Time of the PSM Rate for pT2 Disease Open: Odds ratio 1.09, 95% CI p=0.5 Lap : Odds ratio 0.6, 95% CI p=0.01 LAP OPEN

Evolution Over Time of the PSM Rate for pT3 Disease Open: Odds ratio 1.35, 95% CI p=0.32 Lap : Odds ratio 0.25, 95% CI p=0.06 LAP OPEN

Nerve Resection During the Study Period for Lap.

Analysis of Biochemical Recurrence

Biochemical Recurrence Data

Functional Outcome Measured prospectively By Patient filled quality of life questionnaires

Potency All Preoperatively potent patients Assessed with or without PDE 5 inhibitors

Definition of Potency During the last four weeks, when you had erections with sexual stimulation, how often were your erections hard enough for penetration (entering your partner)? 1.No sexual activity 2.Almost never/never 3.A few times (much less than half of time) 4.Sometimes (about half of the time) 5.Most times (much more than half of the time) 6.Almost always / always

Potency After Bilateral Nerve Preservation Date of Sx

Continence

Definition of Continence How many pads or adult diapers per 24-hour period did you use to control urine leakage during the last four weeks? 1.None (or no leakage) 2.An occasional pad or protective material 3.One pad per 24-hour period 4.Two pads per 24-hour period 5.Three pads or more pads per 24-hour period 6.Adult diapers

Date of Sx (No Pads) 77 50

Analysis of Morbidity

Methods Intraoperative dataIntraoperative data blood loss, OR time Inpatient dataInpatient data Any departure from standard of care, hospital stay Outpatient dataOutpatient data Phone calls, ER / Urgent care visits, rehospitalization, reoperation, within 30 days postoperatively

Methods Prospective:Prospective: Prostate cancer database (for lap only) Reviewed all the complications entered in the DMS for M&M Retrospective:Retrospective: Discharge summary Postoperative Clinic visits Nursing Notes Nursing phone calls documentation Outside correspondence Outside ER visit documentation UCC visit documentation Transfusion records

MSKCC SURGICAL SECONDARY EVENTS GRADING SCALE Complication Grade Description 1Oral medication / bedside care 2Intravenous Medication / Minor Bedside Surgical Procedure 3Interventional Radiology / Endoscopy / Operation / Intubation 4Chronic Disability / Major Organ Resection 5Death

Patients Data Mean age: 59 years for both groups Thromboprophylaxis: Preoperative and postoperative LMWH (lap only) SCD Antibiotic prophylaxis

EQUANIMITY LRPRRP OR Time OR Time (min) (90 – 430) (90-360) EBL EBL (ml) (50 – 1500) ( ) Hospital stay Hospital stay (night) (1 – 17) (2-11)

Blood Transfusion LRPRRP Autologous only 033.6% (233 pts) Auto + Heterologous 09% (67 pts) Heterologous only 2.9% (14 pts)5.5% (38 pts) Overall2.9% (14 pts)49% (338 pts)

Cardiac & Thromboembolic LRPRRP Number (%)GradeNumber (%)Grade DVT1 (0.2%)24 (0.6%)2 PE3 (0.6%)21 (0.14%)2 MI1 (0.2%)21 (0.14%)5 A-Fib3 (0.6%)211 (1.6%)2 Syncope0-8 (1.15%)2

Postoperative “Bounce-back” LRPRRP UCC / Local ER Visits 75 patients (15.5%)75 patients (10.8%) Readmissions (MSK or Local) 23 patients (4.7%)8 patients (1.15%) Reoperations 9 patients (1.8% )*3 patients (0.4%)

Analysis of Cost

Total Hospital Charges

Could the difference be explained by Length of stay?

Conclusions At our institution the laparoscopic and open approach offer comparable cancer control Recovery of erections is slighly faster with laparoscopy, that of continence is faster with open surgery The blood loss and transfusion rate is significantly reduced after laparoscopy